Table 1 Sociodemographic, clinical, and psychological characteristics of the study sample (n = 2,298)
n | % | |
|---|---|---|
Sociodemographic factors | ||
Age at survey (years)M: 69.5 SD: 8.2 | ||
≤ 60 | 315 | 13.7 |
> 60 - ≤70 | 797 | 34.7 |
> 70 | 1,186 | 51.6 |
Partnership | ||
yes | 1,879 | 91.0 |
no | 186 | 9.0 |
Children | ||
0 | 358 | 17.9 |
≥ 1 | 1640 | 82.1 |
Clinical characteristics | ||
Age at surgery (years)M: 65.6 SD: 7.7 | ||
≤ 55 | 221 | 9.6 |
> 55 ≤ 65 | 783 | 34.1 |
> 65 | 1294 | 56.3 |
Time since surgery (years)Mdn: 3; 25th -75th Pctl: 0.5-7 | ||
Preoperative | 212 | 9.2 |
0-≤1 | 562 | 24.5 |
2-≤5 | 810 | 35.2 |
> 5 | 714 | 31.1 |
Second primary cancer | ||
yes | 172 | 7.5 |
no | 2126 | 92.5 |
Family history of PCa | ||
yes | 690 | 30.0 |
no | 1608 | 70.0 |
PSA level at diagnosis (ng/ml) Mdn: 7.3; 25th -75th Pctl: 5.1–10.6 | ||
≤ 4 | 221 | 9.6 |
> 4 ≤ 10 | 1403 | 61.1 |
> 10 | 672 | 29.3 |
ISUP | ||
≤ 1 | 314 | 13.8 |
2/3 | 1581 | 69.5 |
4/5 | 381 | 16.7 |
Organ-confined stage at RP | ||
yes | 1321 | 57.5 |
no | 977 | 42.5 |
Biochemical recurrence | ||
yes | 496 | 22.1 |
no | 1745 | 77.9 |
Ongoing treatment at survey | ||
yes | 204 | 9.8 |
no | 1888 | 90.2 |
ASA-Score | ||
I | 402 | 18.5 |
II | 1491 | 68.4 |
III | 285 | 13.1 |
RCS Charlson Score (at surgery) | ||
0 | 1509 | 85.2 |
1 | 204 | 11.5 |
≥ 2 | 59 | 3.2 |
Psychosocial factors | ||
Depressive symptoms (PHQ-2)M: 1.0; SD: 1.2 | ||
positive screening (≥ 3) | 206 | 9.1 |
negative screening (< 3) | 2052 | 90.9 |
Anxiety symptoms (GAD-2)M: 0.9; SD: 1,1 | ||
positive screening (≥ 3) | 169 | 7.5 |
negative screening (< 3) | 2083 | 92.5 |
Distress (QSC-R10) M: 10.0; SD: 8.7 | ||
high ≥ 15 | 557 | 25.6 |
low < 15 | 1619 | 74.4 |
Psychosocial counseling desired | ||
yes | 480 | 21.5 |
no | 1750 | 78.5 |
Quality of life (QLQ-C30)M: 72.5 SD:18.8 | ||
Perceived severity of disease | ||
no | 343 | 15.2 |
low | 785 | 34.8 |
moderate | 649 | 28.8 |
high | 479 | 21.2 |